ADVFN - Advanced Financial Network.
HOME» NYSE » J » JNJ Stock Price » JNJ Stock News

Johnson & Johnson Share News

 Johnson & Johnson Stock Price
JNJ Stock Price
 Johnson & Johnson Stock Chart
JNJ Stock Chart
 Johnson & Johnson Stock News
JNJ Stock News
 Johnson & Johnson Company Information
JNJ Company Information
 Johnson & Johnson Stock Trades
JNJ Stock Trades

Danaher, Blackstone Working on Bid for J&J's Ortho Unit

Danaher Corp. (DHR) and Blackstone Group LP (BX) are working on a joint bid for Johnson & Johnson's (JNJ) Ortho Clinical Diagnostics unit, Reuters reported Thursday, citing people familiar with the matter. Other bidders include Carlyle Group LP (CG), Bain Capital LLC, BC Partners and a joint approach from CVC Capital Partners and Leonard Green & Partners, Reuters reported. Ortho could be sold for more than $4 billion, the people told Reuters. Full story at http://www.reuters.com/article/2013/11/07/us-jj-sale-idUSBRE9A61FA20131107 Write to nymonitoring@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Johnson & Johnson (JNJ)
DateTimeHeadline
03/21/201716:10:00Johnson & Johnson to Host Investor Conference Call on First-Quarter...
03/16/201717:55:43Statement of Changes in Beneficial Ownership (4)
03/16/201717:55:43Statement of Changes in Beneficial Ownership (4)
03/16/201717:55:43Statement of Changes in Beneficial Ownership (4)
03/15/201708:24:39Additional Proxy Soliciting Materials (definitive) (defa14a)
03/15/201708:19:08Proxy Statement (definitive) (def 14a)
03/14/201702:00:00Johnson & Johnson Names Winners of First Africa Innovation Challenge
03/14/201702:00:00Johnson & Johnson Names Winners of First Africa Innovation Challenge
03/13/201711:35:00Ortho Clinical Diagnostics Announces Expansion Of Global Agreement...
03/13/201711:17:00Ortho Clinical Diagnostics Announces Expansion Of Global Agreement...
03/07/201716:22:54Statement of Changes in Beneficial Ownership (4)
03/03/201717:15:26Current Report Filing (8-k)
03/02/201717:51:54Statement of Changes in Beneficial Ownership (4)
03/02/201717:17:57Statement of Changes in Beneficial Ownership (4)
03/02/201707:29:00Actelion's Founders Start New Biotech, With J&J's Backing
03/01/201716:47:53Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/01/201706:16:35Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/01/201706:16:35Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/01/201706:16:35Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/01/201706:16:35Free Writing Prospectus - Filing Under Securities Act Rules 163/433...

Johnson & Johnson and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US